CARBYLAN THERAPEUTICS INC's ticker is CBYL and the CUSIP is 141384107. A total of 47 filers reported holding CARBYLAN THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $11,000 | +450.0% | 24,645 | +679.9% | 0.00% | – |
| Q2 2016 | $2,000 | -99.0% | 3,160 | -99.0% | 0.00% | – |
| Q1 2016 | $202,000 | -83.2% | 313,908 | -5.4% | 0.00% | – |
| Q4 2015 | $1,201,000 | +4.3% | 331,903 | +3.0% | 0.00% | – |
| Q3 2015 | $1,151,000 | -50.6% | 322,303 | -1.2% | 0.00% | -100.0% |
| Q2 2015 | $2,332,000 | – | 326,137 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 1,178,941 | $4,209,000 | 0.23% |
| SPHERA FUNDS MANAGEMENT LTD. | 400,000 | $1,428,000 | 0.18% |
| PURA VIDA INVESTMENTS, LLC | 80,000 | $286,000 | 0.16% |
| MENTA CAPITAL LLC | 32,229 | $115,000 | 0.02% |
| WEDBUSH SECURITIES INC | 22,300 | $80,000 | 0.02% |
| Omega Advisors Inc. | 98,200 | $351,000 | 0.01% |
| VANGUARD GROUP INC | 5,091,482 | $170,165,000 | 0.01% |
| Alyeska Investment Group, L.P. | 109,241 | $390,000 | 0.01% |
| PUTNAM INVESTMENTS LLC | 635,468 | $2,269,000 | 0.01% |
| Pentwater Capital Management LP | 114,255 | $408,000 | 0.00% |